|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: EMC6 |
Gene summary for EMC6 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | EMC6 | Gene ID | 83460 |
| Gene name | ER membrane protein complex subunit 6 | |
| Gene Alias | RAB5IFL | |
| Cytomap | 17p13.2 | |
| Gene Type | protein-coding | GO ID | GO:0000045 | UniProtAcc | Q9BV81 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 83460 | EMC6 | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.62e-02 | 1.35e-01 | 0.0155 |
| 83460 | EMC6 | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.08e-06 | 3.37e-01 | -0.1808 |
| 83460 | EMC6 | HTA11_1938_2000001011 | Human | Colorectum | AD | 9.82e-09 | 3.73e-01 | -0.0811 |
| 83460 | EMC6 | HTA11_78_2000001011 | Human | Colorectum | AD | 4.32e-02 | 1.49e-01 | -0.1088 |
| 83460 | EMC6 | HTA11_347_2000001011 | Human | Colorectum | AD | 6.17e-15 | 3.85e-01 | -0.1954 |
| 83460 | EMC6 | HTA11_411_2000001011 | Human | Colorectum | SER | 2.97e-04 | 4.19e-01 | -0.2602 |
| 83460 | EMC6 | HTA11_2112_2000001011 | Human | Colorectum | SER | 5.40e-04 | 5.91e-01 | -0.2196 |
| 83460 | EMC6 | HTA11_3361_2000001011 | Human | Colorectum | AD | 1.55e-05 | 2.49e-01 | -0.1207 |
| 83460 | EMC6 | HTA11_83_2000001011 | Human | Colorectum | SER | 6.21e-04 | 2.91e-01 | -0.1526 |
| 83460 | EMC6 | HTA11_696_2000001011 | Human | Colorectum | AD | 7.63e-19 | 3.36e-01 | -0.1464 |
| 83460 | EMC6 | HTA11_866_2000001011 | Human | Colorectum | AD | 1.61e-06 | 2.02e-01 | -0.1001 |
| 83460 | EMC6 | HTA11_1391_2000001011 | Human | Colorectum | AD | 5.06e-19 | 6.43e-01 | -0.059 |
| 83460 | EMC6 | HTA11_2992_2000001011 | Human | Colorectum | SER | 1.39e-02 | 4.87e-01 | -0.1706 |
| 83460 | EMC6 | HTA11_546_2000001011 | Human | Colorectum | AD | 4.39e-03 | 2.56e-01 | -0.0842 |
| 83460 | EMC6 | HTA11_7862_2000001011 | Human | Colorectum | AD | 4.76e-06 | 3.86e-01 | -0.0179 |
| 83460 | EMC6 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.05e-12 | 4.01e-01 | 0.096 |
| 83460 | EMC6 | HTA11_4255_2000001011 | Human | Colorectum | SER | 4.91e-03 | 3.96e-01 | 0.0446 |
| 83460 | EMC6 | HTA11_8622_2000001021 | Human | Colorectum | SER | 1.15e-05 | 4.56e-01 | 0.0528 |
| 83460 | EMC6 | HTA11_10711_2000001011 | Human | Colorectum | AD | 7.98e-04 | 2.02e-01 | 0.0338 |
| 83460 | EMC6 | HTA11_7696_3000711011 | Human | Colorectum | AD | 5.43e-16 | 3.29e-01 | 0.0674 |
| Page: 1 2 3 4 5 6 7 8 9 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer | ||
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma | ||
| Prostate |  | BPH: Benign Prostatic Hyperplasia |
| Skin |  | AK: Actinic keratosis |
| cSCC: Cutaneous squamous cell carcinoma | ||
| SCCIS:squamous cell carcinoma in situ | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:00718165 | Thyroid | PTC | tail-anchored membrane protein insertion into ER membrane | 12/5968 | 17/18723 | 1.20e-03 | 6.89e-03 | 12 |
| GO:00450505 | Thyroid | PTC | protein insertion into ER membrane by stop-transfer membrane-anchor sequence | 8/5968 | 10/18723 | 2.46e-03 | 1.27e-02 | 8 |
| GO:001623623 | Thyroid | ATC | macroautophagy | 169/6293 | 291/18723 | 6.56e-18 | 7.69e-16 | 169 |
| GO:009015031 | Thyroid | ATC | establishment of protein localization to membrane | 150/6293 | 260/18723 | 1.05e-15 | 7.96e-14 | 150 |
| GO:000703322 | Thyroid | ATC | vacuole organization | 100/6293 | 180/18723 | 1.07e-09 | 2.71e-08 | 100 |
| GO:000702921 | Thyroid | ATC | endoplasmic reticulum organization | 51/6293 | 87/18723 | 1.47e-06 | 1.81e-05 | 51 |
| GO:000004522 | Thyroid | ATC | autophagosome assembly | 56/6293 | 99/18723 | 2.22e-06 | 2.63e-05 | 56 |
| GO:190503721 | Thyroid | ATC | autophagosome organization | 57/6293 | 103/18723 | 4.61e-06 | 5.03e-05 | 57 |
| GO:005120516 | Thyroid | ATC | protein insertion into membrane | 35/6293 | 57/18723 | 1.58e-05 | 1.46e-04 | 35 |
| GO:004504813 | Thyroid | ATC | protein insertion into ER membrane | 16/6293 | 22/18723 | 2.03e-04 | 1.35e-03 | 16 |
| GO:007181612 | Thyroid | ATC | tail-anchored membrane protein insertion into ER membrane | 12/6293 | 17/18723 | 2.02e-03 | 9.60e-03 | 12 |
| GO:004505011 | Thyroid | ATC | protein insertion into ER membrane by stop-transfer membrane-anchor sequence | 8/6293 | 10/18723 | 3.60e-03 | 1.58e-02 | 8 |
| Page: 1 2 3 4 5 6 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| EMC6 | insertion | Nonsense_Mutation | novel | c.318_319insAAGATGGAGAGCCATATGCTAAGAAATGTAACCAACACCTAGGA | p.Val107LysfsTer14 | p.V107Kfs*14 | Q9BV81 | protein_coding | TCGA-A2-A0CT-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | cytoxan | SD | ||
| EMC6 | SNV | Missense_Mutation | novel | c.193N>A | p.Leu65Ile | p.L65I | Q9BV81 | protein_coding | tolerated(0.23) | benign(0.076) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
| EMC6 | SNV | Missense_Mutation | rs202001960 | c.241N>T | p.Arg81Trp | p.R81W | Q9BV81 | protein_coding | deleterious(0.02) | probably_damaging(0.998) | TCGA-50-5930-01 | Lung | lung adenocarcinoma | Male | <65 | III/IV | Chemotherapy | taxotere | PD |
| EMC6 | SNV | Missense_Mutation | c.140C>T | p.Thr47Ile | p.T47I | Q9BV81 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-F1-6177-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |